Jeffrey Alan Wolf is Chief Executive Officer of NightHawk Biosciences, Inc.. Currently has a direct ownership of 3.57 Million shares of NHWK, which is worth approximately $571,646. The most recent transaction as insider was on May 16, 2024, when has been sold 2,500,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.57M
0% 3M change
233.04% 12M change
Total Value Held $571,646

Jeffrey Alan Wolf Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 16 2024
BUY
Grant, award, or other acquisition
-
2,500,000 Added 41.17%
3,572,789 Common Stock
Dec 13 2021
BUY
Grant, award, or other acquisition
-
246,305 Added 18.67%
1,072,789 Common Stock
Jan 04 2021
BUY
Grant, award, or other acquisition
-
288,100 Added 27.32%
766,484 Common Stock

Also insider at

SYN
Synthetic Biologics, Inc. Healthcare
JAW

Jeffrey Alan Wolf

Chief Executive Officer
Rockville, MD

Track Institutional and Insider Activities on NHWK

Follow NightHawk Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NHWK shares.

Notify only if

Insider Trading

Get notified when an Night Hawk Biosciences, Inc. insider buys or sells NHWK shares.

Notify only if

News

Receive news related to NightHawk Biosciences, Inc.

Track Activities on NHWK